FLFu Luo

Fu Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fu Luo has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Electroacupuncture Attenuates Cerebral Ischemia/Reperfusion Injury and Enhances Neurological Recovery via Modulating Ferroptosis-Associated Proteins

    by Guanghua Sun, Binwei Liu, Fu Luo, Danni Liu, Jinling Wang, Yang Liu, Huan Guo, Qin Chen, Jun Zhou

    Objective: This study aimed to investigate the effects of electroacupuncture (EA) on cerebral ischemia-reperfusion injury (CIRI), neurological function, and regulatory effects on the expression of ferroptosis-associated proteins in rats. Methods: Thirty-six 3-month-old male Sprague Dawley rats were randomly assigned to sham, CIRI model (model), and CIRI + EA (EA) groups ( n = 12 / group). The CIRI model was induced by left middle cerebral artery occlusion. The EA group received daily EA stimulation at GV26/GV20 (3/15 Hz, 1 mA, 20 min) for 5 days, while the sham group underwent sham treatment. Neurological function (Longa score), serum cytokine levels (ELISA), infarct volume (TTC staining), histopathology (H&E and Nissl staining), and protein/mRNA expression (RT-qPCR/Western blot) were evaluated across the groups. Results: ELISA revealed that EA therapy significantly attenuated serum levels of TNF-α and IL-6 in CIRI rats. Compared with the model group, the EA intervention substantially improved limb motor function and decreased Longa scores in the EA group. TTC, H&E staining, and Nissl staining demonstrated that EA therapy significantly attenuated the cerebral infarction volume percentage and mitigated cortical neuronal damage in CIRI rats. Following EA treatment, the EA group exhibited significantly upregulated GPX4 mRNA and protein expressions in the cerebral cortex compared to the model group, while ACSL4 and TFRC expression levels were significantly downregulated. Conclusion: EA treatment effectively alleviates cerebral tissue damage, attenuates inflammatory responses, and improves neurological function in CIRI model rats. The neuroprotective mechanism may be mediated by regulating oxidative stress, enhancing cellular antioxidant capacity, and modulating ferroptosis-associated proteins (ACSL4, GPX4, and TFRC) in the cerebral cortex.

  • Open Access

    Electroacupuncture Preconditioning Alleviates Lipopolysaccharides-Induced Acute Lung Injury by Downregulating LC3‐II/I and Beclin 1 Expression

    by Guanghua Sun, Yahua Zeng, Fu Luo, Lixian Zhang, Jinqu Tan, Jie Tong, Lu Yang, Danni Liu, Liu Liu, Jun Zhou

    Our study aimed to investigate the effect of electroacupuncture pretreatment on the inflammatory response and expression levels of LC3-II/I and Beclin 1 using a model of lipopolysaccharide (LPS)-induced acute lung injury (ALI). Eighteen male Sprague-Dawley (SD) rats were randomly divided into three groups: normal control group (NC, n = 6), LSP modeling group (LM, n = 6), and electroacupuncture group (EA, n = 6). Rats in the EA group received electroacupuncture pretreatment at bilateral Zusanli (ST36) and Chize (LU5) points for five days (30 min each time daily, frequency; 3 Hz/15 Hz, intensity; 1 mA). Rats in the EA and LM groups were then injected with 5 mg/kg LPS (Beijing, Solarbio Company, concentration; 5 mg/mL) through the tail vein, while those in the NC group were injected with 5 mg/kg saline. The animals were sacrificed six hours after LPS or saline injection through cervical vertebrae by dislocation under deep anesthesia. Orbital blood was collected for the analysis of serum inflammatory factors including interleukin-1β (IL-1β) and transforming growth factor-β (TGF-β). The lower left lung was excised, stained with hematoxylin-eosin (HE), and subjected to histopathological analysis. The mRNA and protein expression of Beclin 1 and LC3 II/I in the lower right lung tissues were detected via RT-qPCR and Western blot analyses, respectively. The results showed that lung injury score was significantly higher in the LM group than that of the NC group ( ) and EA group ( ). The IL-1β contents were significantly decreased in the EA group ( ) than in the LM group. In contrast, the GF-β contents were increased in the EA group significantly when compared with the LM group ( ). RT-qPCR and Western blot detection showed that the relative gene expression of LC3‐II/I and Beclin 1 was significantly lower in the EA group than in the LM group ( ). However, the relative protein expression level of LC3‐II/I and Beclin 1 was slightly lower in the EA group than the in LM group ( ). These results show that electroacupuncture pretreatment reduces the inflammatory response in ALI and can protect lung tissue by inhibiting the gene and protein expression levels of LC3‐II/I and Beclin 1.


  • Open Access

    Electroacupuncture Upregulates HIF-1α and SOX9 Expression in Knee Osteoarthritis

    by Jie Tong, Chengyuan Deng, Guanghua Sun, Jun Zhou, Peirui Zhong, Tiantian Wang, Ye Zeng, Qi Wu, Yuan Liao, Fu Luo, et al.

    Electroacupuncture (EA) has been clinically used in knee osteoarthritis broadly and proved to be effective than other therapies with fewer side effects; however, the mechanism of electroacupuncture to work on cartilage remains unclear. In this study, we aimed to evaluate the effect of EA treatment on cartilage and the relationship between EA and proteins such as HIF-a and SOX9. EA (dilatational wave, 315HZ, 1mA) has been applied to bilateral Zusanli (ST36), Xuehai (SP10), Taixi (KI3), and Yanglingquan (GB34) of rats. Results showed that the cartilage of the knee osteoarthritis group had obvious damage and fissure formation while the EA group showed that the cartilage destruction was generally milder. In addition, the protein expression levels of HIF-1α, and chondrogenic markers such as Sox9, and ACAN in the electroacupuncture group were higher than those in the ACLT group. Also, the extracellular matrix protein expression levels of MMP13 and ADAMTS5 were decreased in the EA group. These findings indicate that EA could alleviate the severity of knee osteoarthritis, and HIF-a and SOX9 may closely attribute to the treatment.